A lawsuit against the genomics company "imposes top-down restrictions" rather than "establishing clear rules" or "letting ...

The National Weather Service issued the heat advisory earlier this week, with temperatures in central Alaska climbing to the ...

UBS has decided Regeneron Pharmaceuticals needs a new wardrobe, trimming its price target from $633 to a more modest $560.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. UBS has ...

Anne Wojcicki, co-founder and former CEO of 23andMe, will regain control of the embattled genetic testing company through a ...

DNA firm is back under old management, Meta is poaching AI talent, TikTok's deadline looms, Kraft goes natural with dyes, and ...

Anne Wojcicki, co-founder and former CEO of 23andMe, has bid to buy back the genetic testing platform, which was pronounced ...

Anne Wojcicki, founder of 23andMe, has successfully repurchased the genetic testing firm out of bankruptcy through her ...

You have less than a month left to file a claim for part of the $30 million class action settlement.

The British data regulator imposed a 2.31 million pound fine against bankrupt genetics research firm 23andMe for "serious" privacy violations tied to the ...

In this week’s edition of InnovationRx, we look at the dangers of RFK Jr.’s vaccine advisory committee, how Trump’s visa ban ...

The ICO has fined genetic testing company 23andMe £2.31 million. It is related to a data breach that impacted the data of 155,592 UK users. The company ...